Breaking News Instant updates and real-time market news.

IEP

Icahn Enterprises

$57.92

-1.65 (-2.77%)

, CVI

CVR Energy

$23.49

2.05 (9.56%)

12:03
12/22/16
12/22
12:03
12/22/16
12:03

Icahn says regulations have become 'literally absurd'

Carl Icahn is speaking on CNBC.

IEP

Icahn Enterprises

$57.92

-1.65 (-2.77%)

CVI

CVR Energy

$23.49

2.05 (9.56%)

IEP Icahn Enterprises
$57.92

-1.65 (-2.77%)

08/18/16
UBSW
08/18/16
DOWNGRADE
Target $30
UBSW
Sell
Icahn Enterprises downgraded to Sell from Neutral at UBS
UBS analyst Brennan Hawken downgraded Icahn Enterprises (IEP) to Sell saying the company's net asset value, despite declining 49% since Q2 of 2015, seems to include optimistic valuations. Icahn uses public comps to value its Tropicana and Viskase (VKSC) holdings rather than using the stocks' publicly traded market values, Hawken tells investors in a research note. He views the public market price as a more valid indicator of fair value. The analyst cut his price target for Icahn Enterprises to $30 from $52. The holding company which Carl Icahn chairs closed yesterday down $1.54 to $58.36.
08/18/16
08/18/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Sell from Hold at Evercore ISI with analyst Ken Sena saying he sees "more risk than reward" ahead of Snapchat's anticipated monetization ramp this fall. 2. Ambev (ABEV) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jeronimo De Guzman saying valuation is full and sees difficult near-term trends ahead given lower disposable income, volume weakness, and lower realized pricing. 3. Icahn Enterprises (IEP) downgraded to Sell from Neutral at UBS saying the company's net asset value, despite declining 49% since second quarter of 2015, seems to include optimistic valuations. 4. Cerulean (CERU) downgraded to Neutral from Buy at Janney Capital, to Market Perform from Outperform at Leerink, and to Market Perform from Outperform at JMP Securities. 5. Magellan Midstream (MMP) downgraded to Underweight at Morgan Stanley with analysts led by Tom Abrams citing a relatively high valuation as the number of lower multiple investment choices has increased. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CVI CVR Energy
$23.49

2.05 (9.56%)

09/08/16
GSCO
09/08/16
UPGRADE
Target $15
GSCO
Neutral
CVR Energy upgraded to Neutral from Sell at Goldman
Goldman Sachs analyst Neil Mehta upgraded CVR Energy to Neutral saying the valuation is more fair with the stock down 70% since his downgrade on November 18, 2014. Mehta raised his price target for the shares to $15 from $13.
09/08/16
GSCO
09/08/16
DOWNGRADE
Target $19
GSCO
Sell
PBF Energy downgraded to Sell from Neutral at Goldman
Goldman Sachs analyst Neil Mehta downgraded PBF Energy (PBF) to Sell saying he expects the company to generate negative free cash flow from 2016-2018 and cut its dividend by 30% in 2018. He views the earnings guidance for acquired refiners at Chalmette and Torrance as aggressive. Mehta cut his six-month price target for the shares to $19 from $23. The analyst post close also upgraded CVR Energy (CVI) to Neutral.
10/10/16
PIPR
10/10/16
UPGRADE
Target $14
PIPR
Neutral
CVR Energy upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Jeff Dietert upgraded CVR Energy (CVI) to Neutral saying the shares are more fairly valued after dropping 61% since January 26. The shares are trading effectively flat with the combined value of the company's core holdings in CVR Refining (CVRR) and CVR Partners (UAN), Dietert tells investors in a research note. The analyst raised his price target for the shares to $14 from $10.

TODAY'S FREE FLY STORIES

A

Agilent

$70.00

1.205 (1.75%)

16:08
11/20/17
11/20
16:08
11/20/17
16:08
Earnings
Agilent sees FY18 adjusted EPS $2.50-$2.56, consensus $2.59 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

MHK

Mohawk

$276.40

4.2 (1.54%)

16:08
11/20/17
11/20
16:08
11/20/17
16:08
Hot Stocks
Mohawk to acquire Godfrey Hirst Group, terms not disclosed »

Mohawk Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

A

Agilent

$69.96

1.17 (1.70%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Agilent sees Q1 adjusted EPS 55c-57c, consensus 60c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

CLSN

Celsion

$2.14

0.14 (7.00%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Initiation
Celsion initiated  »

Celsion initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$28.27

0.37 (1.33%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Urban Outfitters reports Q3 EPS 41c, consensus 33c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VIPS

Vipshop

$9.25

-0.53 (-5.42%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Breaking Earnings news story on Vipshop »

Vipshop sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

A

Agilent

$69.92

1.125 (1.64%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Agilent reports Q4 adjusted EPS 67c, consensus 62c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

VIPS

Vipshop

$9.27

-0.51 (-5.21%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Vipshop reports Q3 adjusted EPS 14c, consensus 14c »

Reports Q3 revenue $2.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ARNC

Arconic

$23.87

0.02 (0.08%)

16:05
11/20/17
11/20
16:05
11/20/17
16:05
Hot Stocks
Arconic to install new horizontal heat treat furnace at Davenport Works facility »

Arconic announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$157.78

1.23 (0.79%)

16:05
11/20/17
11/20
16:05
11/20/17
16:05
Earnings
Intuit reports Q1 EPS (7c), consensus (5c) »

Reports Q1 revenue $886M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SIFI

SI Financial

$14.95

0.35 (2.40%)

16:04
11/20/17
11/20
16:04
11/20/17
16:04
Hot Stocks
SI Financial Chief Credit Officer Gerald Coia to retire »

SI Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

16:03
11/20/17
11/20
16:03
11/20/17
16:03
Earnings
Enanta Pharmaceuticals reports Q4 EPS $1.86, consensus $2.13 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NBIX

Neurocrine

, ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

16:02
11/20/17
11/20
16:02
11/20/17
16:02
Hot Stocks
Neurocrine names Matt Abernethy as CFO »

Neurocrine Biosciences…

NBIX

Neurocrine

ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

  • 14

    Dec

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

, PEGI

Pattern Energy

$22.13

0.14 (0.64%)

15:46
11/20/17
11/20
15:46
11/20/17
15:46
Periodicals
8point3 draws interest from Capital Dynamics, Pattern Energy, Bloomberg says »

Capital Dynamics and…

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

PEGI

Pattern Energy

$22.13

0.14 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VRX

Valeant

$15.64

0.95 (6.47%)

15:40
11/20/17
11/20
15:40
11/20/17
15:40
Options
Valeant calls active as shares see relative strength »

Valeant calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jun

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, GIS

General Mills

$54.23

0.51 (0.95%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Periodicals
General Mills, not Nestle, should buy Hain Celestial, Cramer says »

Following a Bloomberg…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

GIS

General Mills

$54.23

0.51 (0.95%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$156.55

0.9 (0.58%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Options
Intuit options imply 5.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SHPG

Shire

$147.37

2.74 (1.89%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

15:32
11/20/17
11/20
15:32
11/20/17
15:32
Recommendations
Shire, Roche analyst commentary  »

Shire selloff on Roche…

SHPG

Shire

$147.37

2.74 (1.89%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

15:30
11/20/17
11/20
15:30
11/20/17
15:30
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Technical Analysis
Technical View: Time Warner drops on pending antitrust briefing »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.74

0.23 (0.67%)

, TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Periodicals
DOJ antitrust announcement concerns AT&T, Time Warner, NBC reports »

Bloomberg also reported…

T

AT&T

$34.74

0.23 (0.67%)

TWX

Time Warner

$87.93

-0.79 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

MRVL

Marvell

$20.29

0.03 (0.15%)

, CAVM

Cavium

$75.83

-0.47 (-0.62%)

15:27
11/20/17
11/20
15:27
11/20/17
15:27
Recommendations
Marvell, Cavium, Broadcom analyst commentary  »

Marvell price target…

MRVL

Marvell

$20.29

0.03 (0.15%)

CAVM

Cavium

$75.83

-0.47 (-0.62%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 06

    Dec

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

15:24
11/20/17
11/20
15:24
11/20/17
15:24
Technical Analysis
Technical View: Hain Celestial spikes higher, retraces some gains »

The shares have come off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, NSRGY

Nestle

$85.11

0.7 (0.83%)

15:22
11/20/17
11/20
15:22
11/20/17
15:22
Hot Stocks
Hain Celestial surges after report of Nestle weighing potential bid »

Shares of Hain Celestial…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$56.11

1.07 (1.94%)

15:20
11/20/17
11/20
15:20
11/20/17
15:20
Options
Sarepta Therapeutics sees a bullish option play »

Sarepta Therapeutics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.